Aaron Hoffman
Corporate Officer/Principal chez Technion-Israel Institute of Technology
Profil
Dr. Aaron Hoffman, MD, is a Director & Chief Medical Officer at PerAssist Ltd.
and an Associate Professor at Technion-Israel Institute of Technology.
He is on the Board of Directors at PerAssist Ltd.
Dr. Hoffman was previously employed as a Director-Vascular Surgery & Transplantation by Rambam Medical Center, a Member by Israeli Ministry of Health, and a Member by Ministry of Defense.
He received his doctorate degree from The Hebrew University of Jerusalem.
Postes actifs de Aaron Hoffman
Sociétés | Poste | Début |
---|---|---|
Technion-Israel Institute of Technology | Corporate Officer/Principal | 01/03/2011 |
Anciens postes connus de Aaron Hoffman
Sociétés | Poste | Fin |
---|---|---|
Israel Ministry of Defense | Corporate Officer/Principal | - |
Rambam Medical Center | Corporate Officer/Principal | - |
Israel Ministry of Health | Corporate Officer/Principal | - |
PerAssist Ltd.
PerAssist Ltd. Medical SpecialtiesHealth Technology PerAssist Ltd. developed devices to improve blood flow. The firm developed Peri-Boost, a device that offers a viable treatment option for patients facing lower limb amputation due to complications of advanced peripheral artery disease (PAD) patients who are not candidates for angioplasty, atherectomy, or bypass. It has the potential to dramatically reduce the rising number of PVD patients who undergo lower limb amputation due to the inadequate treatment options available. The company was founded by Gaby Weizman and Aaron Hoffman and is headquartered in D.N. Misgav, Israel. | Fondateur | - |
Formation de Aaron Hoffman
The Hebrew University of Jerusalem | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
PerAssist Ltd.
PerAssist Ltd. Medical SpecialtiesHealth Technology PerAssist Ltd. developed devices to improve blood flow. The firm developed Peri-Boost, a device that offers a viable treatment option for patients facing lower limb amputation due to complications of advanced peripheral artery disease (PAD) patients who are not candidates for angioplasty, atherectomy, or bypass. It has the potential to dramatically reduce the rising number of PVD patients who undergo lower limb amputation due to the inadequate treatment options available. The company was founded by Gaby Weizman and Aaron Hoffman and is headquartered in D.N. Misgav, Israel. | Health Technology |
Rambam Medical Center | |
Israel Ministry of Health | Government |
Israel Ministry of Defense | Government |